Covered recipient · General Payments record
AMY R KULAK
Allopathic & Osteopathic Physicians Ophthalmology Ophthalmic Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$3,602.95
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,879.57 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lumenis BE inc | $1,321.05 | 1 |
| Amgen Inc. | $231.22 | 7 |
| Tarsus Pharmaceuticals, Inc. | $116.47 | 4 |
| Bausch & Lomb Americas Inc. | $84.14 | 1 |
| ABBVIE INC. | $82.09 | 3 |
| REVANCE THERAPEUTICS, INC. | $44.60 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.87 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104114978 | CMS |
| ABBVIE INC. | $34.29 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104114980 | CMS |
| ABBVIE INC. | $33.93 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104114982 | CMS |
| Amgen Inc. | $25.69 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111625527 | CMS |
| Amgen Inc. | $5.92 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111625529 | CMS |
| Amgen Inc. | $5.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111625531 | CMS |
| Amgen Inc. | $145.92 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111625533 | CMS |
| Amgen Inc. | $8.25 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111625535 | CMS |
| Amgen Inc. | $16.98 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111625537 | CMS |
| Amgen Inc. | $23.46 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111625539 | CMS |
| Bausch & Lomb Americas Inc. | $84.14 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140299668 | CMS |
| Lumenis BE inc | $1,321.05 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082155532 | CMS |
| REVANCE THERAPEUTICS, INC. | $20.43 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147922244 | CMS |
| REVANCE THERAPEUTICS, INC. | $24.17 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147922246 | CMS |
| Tarsus Pharmaceuticals, Inc. | $32.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139109817 | CMS |
| Tarsus Pharmaceuticals, Inc. | $34.47 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139109819 | CMS |
| Tarsus Pharmaceuticals, Inc. | $31.19 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139109821 | CMS |
| Tarsus Pharmaceuticals, Inc. | $18.81 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139109823 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.